NCT06632743 Austrian Biobanking Study for Sarcopenia
| NCT ID | NCT06632743 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Sarcopenia |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-02-01 |
| Primary Completion | 2033-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2023-02-01 with a primary completion date of 2033-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators aim to set up a biobanking study in Graz, Austria, to study sarcopenia in liver cirrhosis and chronic inflammatory bowel disease by collecting a standardized dataset including routine clinical and biochemical tests; biosamples to assess novel biomarker as well as advanced clinical assessments. In a small country like Austria, a nationwide biobanking study can enhance research enormously. The investigators therefore aim to extend the registry to all tertiary liver care centers in Austria in a second step.
Eligibility Criteria
Inclusion Criteria: * Age \>18y * Informed consent * CT/MRI scan as part of routine care within +/-2 month of the study visit Exclusion Criteria: * Hepatic encephalopathy \> grade 2 and or other cognitive disorder not allowing informed consent * Hepatocellular carcinoma stage BCLC C or D * Any other condition or circumstance, which, in the opinion of the investigator, would affect the patient's ability to participate in the protocol
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06632743 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sarcopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06632743 currently recruiting?
Yes, NCT06632743 is actively recruiting participants. Contact the research team at vanessa.stadlbauer@medunigraz.at for enrollment information.
Where is the NCT06632743 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT06632743 clinical trial?
NCT06632743 is sponsored by Medical University of Graz. The trial plans to enroll 1,000 participants.